CML Microsystems plc (LON:CML) shareholders (or potential shareholders) will be happy to see that the Non-Executive Director, Nathan Zommer, recently bought a whopping UK£1.5m worth of stock, at a ...

The FDA has issued a complete response letter (CRL) to a new drug application (NDA) for Dasynoc for the treatment of chronic ...

CML Microsystems ( ($GB:CML) ) has issued an announcement. CML Microsystems has announced the issuance of new ordinary shares to Non-Executive ...

An unusual white blood cell count can be a sign of chronic myeloid leukemia (CML), a type of blood cancer. CML can affect the balance of white blood cells in the blood and cause them to function ...

CML Microsystems revealed on Wednesday that non-executive director Nathan Zommer had acquired 559,134 ordinary shares in the ...

Newly published data suggests most patients are opting for second- or third-generation tyrosine kinase inhibitors instead of a generic form of imatinib. Patients with chronic myelogenous leukemia (CML ...

A CML diagnosis, often striking young Indian adults, is now more manageable. This guide emphasizes empowering patients by ...

Chronic myelomonocytic leukemia (CMML) and chronic myeloid leukemia (CML) are two types of cancers that affect the blood and bone marrow. In both types, certain blood cells multiply out of control.

Chronic myeloid leukemia (CML) blast crisis phase is the last stage of the condition where there are large clusters of immature white blood cells, or blasts, in the bone marrow, organs, and tissue.

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial ...

Patient adherence to tyrosine kinase inhibitors (TKIs) ranges widely—from 19% to 100%—according to several studies. Most participants in the current study believed in the efficacy of their medication, ...